Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Ophthalmic Anesthetic Drugs Market Size study, By Type (Local, General, Topical, Facial block, Retrobulbar block, Peribulbar block), By Drugs (Proparacaine 0.5%, Tetracaine Hydrochloride, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), and Regional Forecasts 2022-2028

  • BIZ4982875
  • 200 Pages
  • May 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Ophthalmic Anesthetic Drugs Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Ophthalmic anesthetics are local anesthetic eye drops, gels, or ointments that can be injected directly into the eye. Ophthalmic anesthetics drugs are used to block the transmission of pain signals from the nerve endings of the eye to the brain. The rising prevalence of eye disorders, growing investment in the development of healthcare infrastructure facilities, and increasing geriatric population are some significant factors fostering the market demand around the world. For instance, according to the World Health Organization (WHO), the population aged 60 years and above will increase from 605 million in 2000 to 2 billion by 2050. Consequentially, the growing aged population is more likely to suffer from a variety of eye disorders, which is bolstering the demand for Ophthalmic Anesthetic Drugs that lead the global market growth. However, the high cost associated with product development and distribution and several side effects associated with ophthalmic anesthetic drugs impede the growth of the market over the forecast period of 2022-2028. Also, the rising number of research and development activities and increasing number of drug approvals and launches are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Ophthalmic Anesthetic Drugs Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the availability of better funding for the research and development activities and increasing expenditure on the healthcare facilities. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as rising government support, growing population, and the surging prevalence of target diseases, would create lucrative growth prospects for the Ophthalmic Anesthetic Drugs Market across the Asia-Pacific region.

Major market players included in this report are:

F. Hoffmann-La Roche Ltd.

Mylan N.V.

Pfizer Inc.

Novartis AG

Johnson & Johnson

Sun Pharmaceutical Industries Ltd.

Eli Lilly and Company

Cipla Inc.

Lupin

Abbott

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Local

General

Topical

Facial block

Retrobulbar block

Peribulbar block

By Drugs:

Proparacaine 0.5%

Tetracaine Hydrochloride

Others

By End-Users:

Hospitals

Specialty Clinics

Homecare

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Ophthalmic Anesthetic Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Ophthalmic Anesthetic Drugs Market, by Region, 2020-2028 (USD Million)

1.2.2. Ophthalmic Anesthetic Drugs Market, by Type, 2020-2028 (USD Million)

1.2.3. Ophthalmic Anesthetic Drugs Market, by Drugs, 2020-2028 (USD Million)

1.2.4. Ophthalmic Anesthetic Drugs Market, by End-Users, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Ophthalmic Anesthetic Drugs Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Ophthalmic Anesthetic Drugs Market Dynamics

3.1. Ophthalmic Anesthetic Drugs Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Rising prevalence of eye disorders

3.1.1.2. Growing investment for development healthcare infrastructure facilities

3.1.2. Market Challenges

3.1.2.1. High cost associated with product development and distribution

3.1.2.2. Several side effects associated with ophthalmic anesthetic drugs

3.1.3. Market Opportunities

3.1.3.1. Rising number of research and development activities

3.1.3.2. Increasing number of drug approvals and launches

Chapter 4. Global Ophthalmic Anesthetic Drugs Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Ophthalmic Anesthetic Drugs Market, by Type

6.1. Market Snapshot

6.2. Global Ophthalmic Anesthetic Drugs Market by Type, Performance - Potential Analysis

6.3. Global Ophthalmic Anesthetic Drugs Market Estimates & Forecasts by Type, 2018-2028 (USD Million)

6.4. Ophthalmic Anesthetic Drugs Market, Sub Segment Analysis

6.4.1. Local

6.4.2. General

6.4.3. Topical

6.4.4. Facial block

6.4.5. Retrobulbar block

6.4.6. Peribulbar block

Chapter 7. Global Ophthalmic Anesthetic Drugs Market, by Drugs

7.1. Market Snapshot

7.2. Global Ophthalmic Anesthetic Drugs Market by Drugs, Performance – Potential Analysis

7.3. Global Ophthalmic Anesthetic Drugs Market Estimates & Forecasts by Drugs, 2018-2028 (USD Million)

7.4. Ophthalmic Anesthetic Drugs Market, Sub Segment Analysis

7.4.1. Proparacaine 0.5%

7.4.2. Tetracaine Hydrochloride

7.4.3. Others

Chapter 8. Global Ophthalmic Anesthetic Drugs Market, by End-Users

8.1. Market Snapshot

8.2. Global Ophthalmic Anesthetic Drugs Market by End-Users, Performance - Potential Analysis

8.3. Global Ophthalmic Anesthetic Drugs Market Estimates & Forecasts by End-Users, 2018-2028 (USD Million)

8.4. Ophthalmic Anesthetic Drugs Market, Sub Segment Analysis

8.4.1. Hospitals

8.4.2. Specialty Clinics

8.4.3. Homecare

8.4.4. Others

Chapter 9. Global Ophthalmic Anesthetic Drugs Market, Regional Analysis

9.1. Ophthalmic Anesthetic Drugs Market, Regional Market Snapshot

9.2. North America Ophthalmic Anesthetic Drugs Market

9.2.1. U.S. Ophthalmic Anesthetic Drugs Market

9.2.1.1. Type breakdown estimates & forecasts, 2018-2028

9.2.1.2. Drugs breakdown estimates & forecasts, 2018-2028

9.2.1.3. End-Users breakdown estimates & forecasts, 2018-2028

9.2.2. Canada Ophthalmic Anesthetic Drugs Market

9.3. Europe Ophthalmic Anesthetic Drugs Market Snapshot

9.3.1. U.K. Ophthalmic Anesthetic Drugs Market

9.3.2. Germany Ophthalmic Anesthetic Drugs Market

9.3.3. France Ophthalmic Anesthetic Drugs Market

9.3.4. Spain Ophthalmic Anesthetic Drugs Market

9.3.5. Italy Ophthalmic Anesthetic Drugs Market

9.3.6. Rest of Europe Ophthalmic Anesthetic Drugs Market

9.4. Asia-Pacific Ophthalmic Anesthetic Drugs Market Snapshot

9.4.1. China Ophthalmic Anesthetic Drugs Market

9.4.2. India Ophthalmic Anesthetic Drugs Market

9.4.3. Japan Ophthalmic Anesthetic Drugs Market

9.4.4. Australia Ophthalmic Anesthetic Drugs Market

9.4.5. South Korea Ophthalmic Anesthetic Drugs Market

9.4.6. Rest of Asia Pacific Ophthalmic Anesthetic Drugs Market

9.5. Latin America Ophthalmic Anesthetic Drugs Market Snapshot

9.5.1. Brazil Ophthalmic Anesthetic Drugs Market

9.5.2. Mexico Ophthalmic Anesthetic Drugs Market

9.6. Rest of The World Ophthalmic Anesthetic Drugs Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. F. Hoffmann-La Roche Ltd.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Mylan N.V.

10.2.3. Pfizer Inc.

10.2.4. Novartis AG

10.2.5. Johnson & Johnson

10.2.6. Sun Pharmaceutical Industries Ltd.

10.2.7. Eli Lilly and Company

10.2.8. Cipla Inc.

10.2.9. Lupin

10.2.10. Abbott

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Ophthalmic Anesthetic Drugs Market, report scope

TABLE 2. Global Ophthalmic Anesthetic Drugs Market estimates & forecasts by Region 2018-2028 (USD Million)

TABLE 3. Global Ophthalmic Anesthetic Drugs Market estimates & forecasts by Type 2018-2028 (USD Million)

TABLE 4. Global Ophthalmic Anesthetic Drugs Market estimates & forecasts by Drugs 2018-2028 (USD Million)

TABLE 5. Global Ophthalmic Anesthetic Drugs Market estimates & forecasts by End-Users 2018-2028 (USD Million)

TABLE 6. Global Ophthalmic Anesthetic Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 7. Global Ophthalmic Anesthetic Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 8. Global Ophthalmic Anesthetic Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global Ophthalmic Anesthetic Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global Ophthalmic Anesthetic Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global Ophthalmic Anesthetic Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global Ophthalmic Anesthetic Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global Ophthalmic Anesthetic Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global Ophthalmic Anesthetic Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. Global Ophthalmic Anesthetic Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. U.S. Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 17. U.S. Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 18. U.S. Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 19. Canada Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 20. Canada Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. Canada Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 22. UK Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 23. UK Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. UK Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 25. Germany Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 26. Germany Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. Germany Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 28. RoE Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 29. RoE Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. RoE Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 31. China Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 32. China Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. China Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 34. India Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 35. India Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. India Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 37. Japan Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 38. Japan Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. Japan Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 40. RoAPAC Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 41. RoAPAC Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. RoAPAC Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 43. Brazil Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 44. Brazil Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Brazil Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 46. Mexico Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 47. Mexico Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. Mexico Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 49. RoLA Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 50. RoLA Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. RoLA Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 52. Row Ophthalmic Anesthetic Drugs Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 53. Row Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. Row Ophthalmic Anesthetic Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 55. List of secondary sources, used in the study of global Ophthalmic Anesthetic Drugs Market

TABLE 56. List of primary sources, used in the study of global Ophthalmic Anesthetic Drugs Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research